The Human Cytomegalovirus Envelope Glycoprotein B Market size is expected to grow at an annual average of 4% during 2022-2028. Human cytomegalovirus envelope glycoprotein B (gB) Human cytomegalovirus envelope glycoprotein B plays an important role in host cell entry and intercellular virus transmission. It is involved in initial adhesion by binding to heparan sulfate with a gM/gN complex that binds heparin with higher affinity. It interacts with the host integrins ITGB1, PDGFRA and EGFR, which are likely to act as entry receptors after attachment. Participates in the fusion of the virus with the cell membrane, allowing the virus to enter the host cell.
(Get 15% Discount on Buying this Report)
A full report of Human Cytomegalovirus Envelope Glycoprotein B Market is available at: https://orionmarketreports.com/human-cytomegalovirus-envelope-glycoprotein-b-market/85300/
The following segmentation are covered in this report:
By Application
- Infectious Disease
- Oncology
- Women’s Health
- Others
By Type
- CSJ-148
- CyMVectin
- TRL-345
- PPCM
- Cytomegalovirus Vaccine
- Others
Company Profile
- Astellas Pharma Inc.
- Trellis Bioscience, Inc.
- Vakzine Projekt Management GmbH
- VBI Vaccine Inc
- Vical Incorporated
The report covers the following objectives:
- Proliferation and maturation of trade in the global Human Cytomegalovirus Envelope Glycoprotein B Market
- The market share of the global Human Cytomegalovirus Envelope Glycoprotein B Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Human Cytomegalovirus Envelope Glycoprotein B Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Human Cytomegalovirus Envelope Glycoprotein B Market
Scope of the report
The research study analyses the Human Cytomegalovirus Envelope Glycoprotein B Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Human Cytomegalovirus Envelope Glycoprotein B Market Report
- What was the Human Cytomegalovirus Envelope Glycoprotein B Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
- What will be the CAGR of Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the Human Cytomegalovirus Envelope Glycoprotein B Market was the market leader in 2022?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
